# Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antibodies-against-vascular-endothelial-growth-factor-improve-early-renal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | An S. De Vriese,Ronald G. Tilton,Marlies Elger,Clifford Stephan,Wilhelm Kriz,Norbert Lameire |
| Citations | 445 |
| DOI | 10.1681/asn.v125993 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2101417448 |
| PMID | 11316858 |
| Type | article |
| Year | 2001 |

## Paper authors

- [An S. De Vriese](https://scholariq.org/researchers/an-s-de-vriese/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

## Paper topics

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.